This agreement, formally signed yesterday in a ceremony that took place at the Lisbon City Hall, will allow women under 50 in the city to undergo free breast cancer screenings. This initiative, set to be implemented by the end of the year, aims to tackle the alarming rise in cancer incidence among younger women.

Through the provision of these two-year collaborative research grants, the Chan Zuckerberg Initiative (CZI) programme aims to accelerate cutting-edge research and technology in metabolism and metabolic physiology. The objective of these grants is to map, measure, and integrate metabolism across different scales—from molecules and organelles to cells and tissues—deepening our understanding of human biology, and to investigate the metabolic processes that maintain physiological homeostasis.

The Champalimaud Foundation, a private non-profit research institution located in Lisbon, Portugal, has achieved a significant milestone in cancer research and pre-clinical development by obtaining exclusive rights to deploy synthetic biology technologies initially licensed from Stanford University and further developed by Refuge Biotechnologies (Refuge), a pioneering synthetic biology company specialising in cancer immunotherapy.

A novel infrastructure for storing, consulting and analysing medical data will be presented at the Open Day of the Champalimaud Foundation (FC) Breast Unit, which is taking place today, October 16. It was created by the Unit's Digital Surgery Lab, a multidisciplinary team led by surgeon Pedro Gouveia, in partnership with the telecommunications company Altice and the Portuguese company BMD Software.

On October 1st, people in over 150 countries across the globe will celebrate the power of music to unite and contribute towards a more peaceful, joyful, and harmonious society during International Music Day. Here at the Champalimaud Foundation, we have several budding musicians, so we asked one of them to give us some insight into combining music with science.

A side-effect “is any effect of a drug, chemical, or other medicine that is in addition to its intended effect, especially an effect that is harmful or unpleasant”. 

In the midst of a territory that has long been a hotspot for armed confrontation and humanitarian instability, the St John of Jerusalem Eye Hospital Group (SJEHG) has managed to provide top quality eye care, as well as ophthalmic training to local medical professionals. 

“For its commitment to providing essential eye care in a region marked by conflict”, the Group has now been recognized with the one-million-euro 2023 António Champalimaud Vision Award, the Champalimaud Foundation announced in a statement.